{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:51:30Z","timestamp":1782413490352,"version":"3.54.5"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The long-term prognosis of patients supported by durable left ventricular assist devices (LVAD) while receiving immunosuppressive therapy remains unclear. Underlying conditions such as cardiac sarcoidosis, recurrent myocarditis, or post-organ transplantation may necessitate concomitant immunosuppressive therapy during LVAD support. In particular, patients requiring prolonged immunosuppressive therapy exceeding low-dose corticosteroids represent a clinically challenging population in whom infectious complications and long-term outcomes have not been well characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>We retrospectively reviewed 241 consecutive LVAD recipients (HeartMate II and HeartMate 3) at a single centre (2013\u201324). Five patients (2.1%) required prolonged immunosuppressive therapy exceeding low-dose corticosteroids. Underlying cardiac conditions included myocarditis (n = 3), cardiac sarcoidosis (n = 1), and dilated cardiomyopathy following liver transplantation (n = 1). The mean duration of immunosuppressive therapy during LVAD support was 2.3 years (0.8\u20134.5 years). One patient developed LVAD-specific infections including driveline infection. Two underwent successful heart transplantation without perioperative complications. One was tapered to low-dose corticosteroid monotherapy due to a non-device-related infection, and two remained stable on LVAD support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case series underscores the complexity of managing LVAD patients requiring extended immunosuppressive therapy and highlights a unique and underreported patient population. Our findings suggest that successful heart transplantation may be achievable in immunosuppressed LVAD patients when supported by vigilant infection surveillance and individualized treatment strategies. This topic is of increasing clinical importance, particularly in regions where DT indications have recently been expanded.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag455","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:53:53Z","timestamp":1782302033000},"source":"Crossref","is-referenced-by-count":0,"title":["Infectious complications and transplant outcomes in durable left ventricular assist device patients receiving immunosuppressive therapy: case series"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8242-1267","authenticated-orcid":false,"given":"Hirotaka","family":"Kawauchi","sequence":"first","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe Shin-machi, Suita, Osaka 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-390X","authenticated-orcid":false,"given":"Takuma","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe Shin-machi, Suita, Osaka 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9481-8860","authenticated-orcid":false,"given":"Satsuki","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center , 6-1 Kishibe Shin-machi, Suita, Osaka 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3282-1327","authenticated-orcid":false,"given":"Chisato","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center , 6-1 Kishibe Shin-machi, Suita, Osaka 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-6940","authenticated-orcid":false,"given":"Yasumasa","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe Shin-machi, Suita, Osaka 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"2026062514314160800_ytag455-B1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.healun.2017.08.002","article-title":"Japanese registry for mechanically assisted circulatory support: first report","volume":"36","author":"Nakatani","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026062514314160800_ytag455-B2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11748-019-01227-y","article-title":"The second official report from Japanese registry for mechanical assisted circulatory support (J-MACS): first results of bridge to bridge strategy","volume":"68","author":"Kinugawa","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2026062514314160800_ytag455-B3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.athoracsur.2022.11.023","article-title":"The Society of Thoracic Surgeons Intermacs 2022 annual report: focus on the 2018 heart transplant allocation system","volume":"115","author":"Yuzefpolskaya","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"2026062514314160800_ytag455-B4","article-title":"Urgent need to address infectious diseases due to immunosuppressive therapies","volume":"10","author":"Chastain","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"2026062514314160800_ytag455-B5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.humimm.2009.10.012","article-title":"Peripheral blood mononuclear cell transcriptome profiles suggest T-cell immunodeficiency in patients with chronic heart failure","volume":"71","author":"Sinha","year":"2010","journal-title":"Hum Immunol"},{"key":"2026062514314160800_ytag455-B6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)10359-8","article-title":"Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device","volume":"354","author":"Ankersmit","year":"1999","journal-title":"Lancet"},{"key":"2026062514314160800_ytag455-B7","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.athoracsur.2008.01.050","article-title":"Cellular immunity impaired among patients on left ventricular assist device for 6 months","volume":"85","author":"Kimball","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026062514314160800_ytag455-B8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0003-4975(03)00480-6","article-title":"Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications","volume":"75","author":"Itescu","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"2026062514314160800_ytag455-B9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s42358-021-00205-4","article-title":"The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients","volume":"61","author":"Stacy","year":"2021","journal-title":"Adv Rheumatol"},{"key":"2026062514314160800_ytag455-B10","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.athoracsur.2011.05.080","article-title":"Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial","volume":"92","author":"John","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2026062514314160800_ytag455-B11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.athoracsur.2012.10.080","article-title":"Impact of ventricular assist device complications on posttransplant survival: an analysis of the united network of organ sharing database","volume":"95","author":"Healy","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2026062514314160800_ytag455-B12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.athoracsur.2012.05.074","article-title":"Driveline infections in left ventricular assist devices: implications for destination therapy","volume":"94","author":"Sharma","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2026062514314160800_ytag455-B13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MAT.0000000000000653","article-title":"Use of durable continuous-flow ventricular assist devices in patients on immunosuppression","volume":"64","author":"Sorabella","year":"2018","journal-title":"ASAIO J"},{"key":"2026062514314160800_ytag455-B14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.athoracsur.2023.11.004","article-title":"The Society of Thoracic Surgeons Intermacs 2023 annual report: focus on magnetically levitated devices","volume":"117","author":"Jorde","year":"2024","journal-title":"Ann Thorac Surg"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/6\/ytag455\/68614531\/ytag455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/6\/ytag455\/68614531\/ytag455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:31:50Z","timestamp":1782412310000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag455\/8716556"}},"subtitle":[],"editor":[{"given":"Edoardo","family":"Zancanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Tamas","family":"Alexy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Alaeldin","family":"Addas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Francesca","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Naoki","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag455","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6,1]]},"article-number":"ytag455"}}